Comparative cancer survival information in Europe

European Journal of Cancer

Volumn 45, Issue 6, 2009, Pages 901-908

  Berrino, Franco ^a   Verdecchia, Arduino ^b   Lutz, Jean Michel ^c   Lombardo, Claudio ^d   Micheli, Andrea ^a   Capocaccia, Riccardo ^b   Black, R J ^e   Brewster, D H ^e   Steward, J A ^f   Oberaigner, W ^g   Hackl, M ^h   Van Eycken, E ⁱ   Verstreken, Martine ⁱ   Holub, J ^j   Jurickova, L ^j   Storm, H H ^k   Engholm, G ^k   Hakulinen, T ^l   Belot, A ^m   Hedelin G ⁿ   Velten, M ⁿ   Tron, I ^o   Le Gall, E ^o   Launoy, G ^p   Guizard, A V ^q   Faivre, J ^r   Bouvier, A M ^r   Carli, P M ^s   Maynadie M ^s   Danzon, A ^t   Buemi, A ^u   Tretarre, B ^v   Lacour, B ^w   Desandes, E ^w   Colonna, M ^x   Molinie F ^y   Bara, S ^z   Schvartz, C ^aa   Ganry, O ^ab   Grosclaude, P ^ac   Brenner, H ^ad   Kaatsch, P ^ae   Ziegler, H ^af   Tryggvadottir, L ^ag   Comber, H ^ah   Berrino, F ^a   Allemani, C ^a   Baili, P ^a   Ciampichini, R ^a   Ciccolallo, L ^a   Gatta, G ^a   Micheli, A ^a   Sant, M ^a   Sowe, S ^a   Zigon, G ^a   Tagliabue, G ^ai   Contiero, P ^ai   Bellu F ^aj   Giacomin, A ^ak   Ferretti, S ^al   Dal Maso, D Serraino L ^am   De Dottori, M ^am   De Paoli, A ^am   Zanier, L ^am   Vercelli, M ^an   Orengo, M A ^an   Casella, C ^an   Quaglia, A ^an   Pannelli, F ^ao   Federico, M ^ap   Rashid, I ^ap   Cirilli, C ^ap   Fusco, M ^aq   Traina, A ^ar   De Lisi, V ^as   Bozzani, F ^as   Magnani, C ^at   Pastore, G ^at   Tumino, R ^au   La Rosa, M G ^au   Spata, E ^au   Sigona, A ^au   Mangone, L ^av   Falcini, F ^aw   Foca, F ^aw   Giorgetti, S ^aw   Senatore, G ^ax   Iannelli, A ^ax   Budroni, M ^ax   Zanetti, R ^ay   Patriarca, S ^ay   Rosso, S ^ay   Piffer, S ^az   Franchini, S ^az   Paci, E ^ba   Crocetti, E ^ba   La Rosa, F ^bb   Stracci, F ^bb   Cassetti, T ^bb   Zambon, P ^bc   Guzzinati, S ^bc   Caldora, M ^b   Capocaccia, R ^b   Carrani, E ^b   De Angelis, R ^b   Francisci, S ^b   Grande, E ^b   Inghelmann, R ^b   Lenz, H ^b   Martina, L ^b   Roazzi, P ^b   Santaquilani, M ^b   Simonetti, A ^b   Tavilla, A ^b   Verdecchia, A ^b   Dalmas, M ^bd   Langmark, F ^be   Bray, F ^be   Johannesen, T B ^be   Rachtan, J ^bf   Gozdz S ^bg   Siudowska, U ^bg   Mezyk R ^bg   Bielska Lasota, M ^bh   Zwierko, M ^bh   Pinheiro, P S ^bi   Primic Zakelj M P Z ^bj   Mateos, A ^bk   Izarzugaza, I ^bl   Torrella Ramos, A ^bm   Zurriaga, Oscar ^bm   Marcos Gragera, R ^bn   Vilardell, M L ^bn   Izquierdo, A ^bn   Martinez Garcia, C ^bo   Sanchez M J ^bo   Navarro, C ^bp   Chirlaque, M D ^bp   Peris Bonet, R ^bq   Ardanaz, E ^bp   Moreno, C ^bp   Galceran, J ^br   Klint, A ^bs   Talback M ^bs   Jundt, G ^bt   Usel, M ^bu   Frick, H ^bv   Ess, S M ^bw   Bordoni, A ^bx   Luthi, J C ^by   Konzelmann, I ^by   Probst, N ^bz   Lutz, J M ^ca   Pury, P ^ca   Visser, O ^cb   Otter, R ^cc   Schaapveld, M ^cc   Coebergh, J W W ^cd   Janssen Heijnen, M L ^cd   Van Der Heijden, Louis ^cd   Greenberg, D C ^ce   Coleman, M P ^cf   Woods, Laura ^cf   Moran, T ^cg   Forman, D ^ch   Cooper, N ^ci   Roche, M ^cj   Verne, J ^cg   Moller H ^ck   Meechan, D ^cl   Poole, J ^cl   Lawrence, G ^cm   Stiller, C ^cn   Gavin, A ^co   more..

^a NATIONAL CANCER INSTITUTE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF GENOA   (Italy)

^e Scottish Cancer Registry   (United Kingdom)

^f Welsh Cancer Intelligence and Surveillance Unit   (United Kingdom)

^g Tyrol Cancer Registry   (Austria)

^h Austrian National Cancer Registry   (Austria)

ⁱ Flemish Cancer Registry   (Belgium)

^j West Bohemia Cancer Registry   (Czech Republic)

^k DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^l FINNISH CANCER REGISTRY   (Finland)

^m FRANCIM   (France)

ⁿ Cancer Registry of Bas Rhin   (France)

^o Bretagne Childhood Cancer Registry   (France)

^p Calvados Digestive Cancer Registry   (France)

^q Calvados General Cancer Registry   (France)

^r ote d'Or Digestive Cancer Registry   (France)

^s EA 4184   (France)

^t Doubs Cancer Registry   (France)

^u Haut Rhin Cancer Registry   (France)

^v Herault Cancer Registry   (France)

^w Lorraine Childhood Cancer Registry   (France)

^x Isere's Cancer Registry   (France)

^y Loire Atlantique Breast and Colon Cancer Registry   (France)

^z Manche Cancer Registry   (France)

^aa Marne Thyroid Cancer Registry   (France)

^ab Somme Cancer Registry   (France)

^ac Tarn Cancer Registry   (France)

^ad GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ae German Childhood Cancer Registry   (Germany)

^af Saarland Cancer Registry   (Germany)

^ag Icelandic Cancer Registr   (Iceland)

^ah National Cancer Registry of Ireland   (Ireland)

^ai Istituto Nazionale dei Tumori   (Italy)

^aj Registro Tumori Adige Tumor Register Sudtirol   (Italy)

^ak Biella Cancer Registry   (Italy)

^al Ferrara Cancer Registry   (Italy)

^am Friuli Venezia Giulia Cancer Registry   (Italy)

^an UNIVERSITY OF GENOA   (Italy)

^ao Macerata Province Cancer Registry   (Italy)

^ap MODENA CANCER REGISTRY   (Italy)

^aq Napoli Cancer Registry   (Italy)

^ar Palermo Breast Cancer Registry   (Italy)

^as PARMA CANCER REGISTRY   (Italy)

^at Piedmont Childhood Cancer Registry   (Italy)

^au CIVILE M P AREZZO HOSPITAL   (Italy)

^av Reggio Emilia Cancer Registry   (Italy)

^aw Romagna Cancer Registry IRST   (Italy)

^ax Salerno Cancer Registry   (Italy)

^ay Cancer Research Centre Torino   (Italy)

^az Osservatorio Epidemiologico   (Italy)

^ba Tuscan Cancer Registry   (Italy)

^bb Umbria Cancer Registry   (Italy)

^bc VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^bd Malta National Cancer Registry   (Malta)

^be CANCER REGISTRY OF NORWAY   (Norway)

^bf Cracow Cancer Registry   (Poland)

^bg Holycross Cancer Centre (HCC)   (Poland)

^bh INSTITUTE OF ONCOLOGY   (Poland)

^bi Southern Portugal Cancer Registry   (Portugal)

^bj INSTITUTE OF ONCOLOGY   (Slovenia)

^bk Albacete Cancer Registry   (Spain)

^bl Basque Country Cancer Registry   (Spain)

^bm Castellon Cancer Registry   (Spain)

^bn Girona Cancer Registry   (Spain)

^bo Granada Cancer Registry   (Spain)

^bp CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^bq UNIVERSITY OF VALENCIA   (Spain)

^br Tarragona Cancer Registry   (Spain)

^bs Cancer Registry of Sweden   (Sweden)

^bt Cancer Registry of Basel   (Switzerland)

^bu GENEVA CANCER REGISTRY   (Switzerland)

^bv Grisons Cancer Registry   (Switzerland)

^bw St Gall Cancer Registry   (Switzerland)

^bx Ticino Cancer Registry   (Switzerland)

^by Valais Cancer Registry   (Switzerland)

^bz Cancer Registry   (Switzerland)

^ca Ticino Cancer Registry ^*  (Switzerland)

^cb Cancer Center Amsterdam   (Netherlands)

^cc Integraal Kankercentrum Noord Nederland   (Netherlands)

^cd Eindhoven Cancer Registry   (Netherlands)

^ce Eastern Cancer Registration and Information Centre   (United Kingdom)

^cf LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^cg Eindhoven Cancer Registry ^*  (United Kingdom)

^ch Northern and Yorkshire Cancer Registry and Information Service   (United Kingdom)

^ci OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^cj UNIVERSITY OF OXFORD   (United Kingdom)

^ck Thames Cancer Registry   (United Kingdom)

^cl Trent Cancer Registry   (United Kingdom)

^cm W Midlands Cancer Intelligence Unit   (United Kingdom)

^cn Childhood Cancer Research Group   (United Kingdom)

^co Northern Ireland Cancer Registry   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ADMINISTRATIVE PERSONNEL; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CANCER SURVIVOR; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DATA BASE; DRUG APPROVAL; EUROPE; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HUMAN; INFORMATION DISSEMINATION; MEDICAL PERSONNEL; NEOPLASM; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

EID: 62549095267     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.01.018     Document Type: Note

References (50)

1. Coleman P., Alexe D.M., Albreht T., and Mckee C.M. Responding to the challenge of cancer in Europe (2008), Institute of Public Health of the Republic of Slovenia, Ljubljana
2. Micheli A., Capocaccia R., Martinez C., et al. Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health 13 (2003) 116-118
3. Micheli A., Berrino F., Paci E., Verdecchia A., and Pierotti M.A. Strategies for cancer control in Italy. Tumori 93 (2007) 329-336
4. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J. Survival of cancer patients in Europe.The EUROCARE study. IARC Scientific Publications no. 132. Lyon: IARC Press; 1995.
5. Berrino F, Capocaccia R, Estève J, et al. Survival of cancer patients in Europe: the EUROCARE -2 study. IARC Scientific Publications no. 151. Lyon: IARC Press; 1999.
6. Coebergh J.W.W., Sant M., Berrino F., et al. Survival of adult cancer patients in Europe diagnosed from 1978-1989: the EUROCARE II Study. Eur J Cancer 34 (1998) 2137-2277
7. Capocaccia R., Gatta G., Magnani C., Stiller C., and Coebergh J.W.W. Childhood cancer survival in Europe 1978-1992: the EUROCARE Study. Eur J Cancer 37 (2001) 671-816
8. Terracini B., Coebergh J.W., Gatta G., et al. Childhood cancer survival in Europe: an overview. Eur J Cancer 37 (2001) 810-816
9. Berrino F., Capocaccia R., Coleman M.P., et al. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 14 suppl 5 (2003) v1-v155
10. Sankila R., Martos Jiménez M.C., Miljus D., et al. Geographical comparison of cancer survival in European children (1988-1997): report from the automated childhood cancer information system project. Eur J Cancer 42 (2006) 1972-1980
11. Sant M., Capocaccia R., Coleman M.P., et al. Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer 37 (2001) 1659-1667
12. Verdecchia A., Guzzinati S., Francisci S., et al., the EUROCARE Working Group. Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 45 (2009) 1042-1066
13. Howard R. Organizing a comprehensive framework for cancer control. In: Coleman M., Alexe D.M., Albreht T., and Mckee M. (Eds). Responding to the challenge of cancer in Europe (2008), Institute of Public Health of the Republic of Slovenia, Ljubljana 113-133
14. Micheli A., Francisci S., Baili P., and De Angelis R. Current cancer profiles of the Italian regions. Tumori 93 (2007) 329-408
15. Fisch T., Pury P., Probst N., et al. Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol 16 (2005) 1882-1888
16. Coleman M.P., Rachet B., Woods L.M., et al. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 90 (2004) 1367-1373
17. Rachet B., Woods L.M., Mitry E., et al. Cancer survival in England and Wales at the end of the 20th century. Br J Cancer 99 Suppl 1 (2008) S2-S10
18. Christensen L.H., Engholm G., Ceberg J., et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?-a population-based study. Eur J Cancer 40 (2004) 1233-1243
19. Brenner H., Francisci S., De Angelis R., et al., the EUROCARE Working Group. Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer 45 (2009) 1028-1041
20. Verdecchia A., Francisci S., Brenner H., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8 (2007) 784-796
21. De Angelis R., Francisci S., Baili P., et al., the EUROCARE Working Group. The EUROCARE-4 database on cancer survival in Europe: Data standardisation, quality control and methods of statistical analysis. Eur J Cancer 45 (2009) 909-930
22. Francisci S., Capocaccia R., Grande E., et al., the EUROCARE Working Group. The cure of cancer: A European perspective. Eur J Cancer 45 (2009) 1067-1079
23. Rosso S., De Angelis R., Ciccolallo L., et al., the EUROCARE Working Group. Multiple tumours in survival estimates. Eur J Cancer 45 (2009) 1080-1094
24. Sant M., Allemani C., Santaquilani M., et al., the EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 95 (2009) 931-991
25. Berrino F., De Angelis R., Sant M., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 (2007) 773-783
26. Robinson D., Sankila R., Hakulinen T., and Moller H. Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. Eur J Cancer 43 (2007) 909-913
27. Organization for economic Co-operation and development (OECD). OECD Health Data 2004. 1st ed. Paris: OECD; 2004.
28. Irwig L., and Armstrong B. EUROCARE-2: relevance for assessment of quality of cancer services?. Lancet 355 (2000) 427-428
29. Autier P., Boniol M., Héry C., Masuyer E., and Ferlay J. Cancer survival statistics should be viewed with caution. Lancet Oncol 8 (2007) 1050-1052
30. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W.W. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 (2008) 1345-1389
31. Lutz J.M., Pury P., Fioretta G., and Raymond L. The impact of coding process on observed cancer mortality trends in Switzerland. Eur J Cancer Prev 13 (2004) 77-81
32. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
33. Mott M.G. Neoplasia in childhood-25 years of progress. Ann Oncol 6 Suppl 1 (1995) 3-8
34. Gatta G., Capocaccia R., Stiller C., Kaatsch P., Berrino F., and Terenziani M. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 23 (2005) 3742-3751
35. Zorzi M., Puliti D., Vettorazzi M., et al. Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997-2001). Br J Cancer 95 (2006) 1265-1268
36. Sikora K. Drugs for cancer. In: Coleman M., Alexe D.M., Albreht T., and Mckee M. (Eds). Responding to the challenge of cancer in Europe (2008), Institute of Public Health of the Republic of Slovenia, Ljubljana 93-112
37. Visser O., and van Leeuwen F.E. Stage-specific survival of epithelial cancers in North-Holland /Flevoland, The Netherlands. Eur J Cancer 41 (2005) 2321-2330
38. Sukel M.P., van de Poll-Franse L.V., Nieuwenhuijzen G.A., et al. Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands. Eur J Cancer 44 (2008) 1846-1854
39. Engel J., Kerr J., Eckel R., et al. Quality of treatment in routine care in a population sample of rectal cancer patients. Acta Oncol 44 (2005) 65-74
40. Visser O., Bakx R., Zoetmulder F.A., et al. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in Greater Amsterdam. J Surg Oncol 95 (2007) 447-454
41. van de Poll-Franse L.V., Houterman S., Janssen-Heijnen M.L., Dercksen M.W., Coebergh J.W., and Haak H.R. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120 (2007) 1986-1992
42. Engel J., Kerr J., Eckel R., et al. Influence of hospital volume on local recurrence and survival in a population sample of rectal cancer patients. Eur J Surg Oncol 31 (2005) 512-520
43. Storm H.H., and Engholm G. Relative survival of Danish cancer patients diagnosed 1981 to 1997 and followed to 2001. A status report. Ugeskr Laeger 164 (2002) 2855-2864
44. Iversen L.H., Norgaard M., Jepsen P., et al. Trends in colorectal cancer survival in northern Denmark: 1985-2004. Colorectal Dis 9 (2007) 210-217
45. Kerr D., Bevan H., Gowland B., Penny J., and Berwick D. Redesigning cancer care. Br Med J 324 (2002) 164-166
46. Sant M., Allemani C., Berrino F., et al. Breast carcinoma survival in Europe and the United States. Cancer 100 (2004) 715-722
47. Sant M., Allemani C., Capocaccia R., et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106 (2003) 416-422
48. Gatta G., Capocaccia R., Sant M., et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 47 (2000) 533-538
49. Telesca D., Etzioni R., and Gulati R. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends. Biometrics 64 (2008) 10-19
50. Dalton S.O., Schuz J., Engholm G., et al. Social inequality in incidence of and survival from cancer in a population-based study in Denmark, 1994-2003: summary of findings. Eur J Cancer 44 (2008) 2074-2085